Get started
Author

Laura Ciaffi

Observed names: CIAFFI, Laura, Ciaffi L., Ciaffi laura, Ciaffi, Laura, L Ciaffi, L. Ciaffi, LAURA CIAFFI
Observed institutions: Université de Yaoundé I, Vita-Salute San Raffaele University, Inserm, Swiss Tropical and Public Health Institute, Université de Dschang, University of Milan, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Central Hospital of Yaoundé, University Hospital of Geneva, Institut de Recherche pour le Développement, Centre Pasteur du Cameroun, Médecins Sans Frontières‎, Médecins Sans Frontières, Médecins Sans Frontières, Institut de Recherche Pour le Développement, Institut de Recherche pour le Développement, Recherches Translationnelles sur le VIH et les Maladies Infectieuses, European Organization for Nuclear Research, Instituut voor Tropische Geneeskunde
ORCID: 0000-0003-4829-0935
Observed ORCID: 0000-0003-4829-0935
OpenAlex ID: A5025754562
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
2020 · Alexandra Calmy, Tamara Tovar Sanchez, et al. · The Lancet HIV · 163
Buruli Ulcer Disease in Cameroon Rediscovered
2004 · JÜRGEN NOESKE, CHRISTOPHER KUABAN, et al. · American Journal of Tropical Medicine and Hygiene · 88
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
2017 · Laura Ciaffi, Sinata Koulla-Shiro, et al. · The Lancet HIV · 76
SARS-CoV-2 Antibody Seroprevalence and Associated Risk Factors in an Urban District in Cameroon
2021 · Kene Nwosu, Joseph Fokam, et al. · Nature Communications · 61
PDF
Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
2018 · Stockdale, Alexander J, Saunders, Matthew J, et al. · Bern Open Repository and Information System (University of Bern) · 61
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial
2013 · Maryline Bonnet, Nilesh Bhatt, et al. · The Lancet Infectious Diseases · 51
Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting
2019 · Nongodo Firmin Kaboré, Armel Poda, et al. · BMC Nephrology · 47
PDF
Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon
2005 · Anke Bourgeois, Christian Laurent, et al. · Antiviral Therapy · 47
Impact of Human Immunodeficiency Virus on the Severity of Buruli Ulcer Disease: Results of a Retrospective Study in Cameroon
2014 · Vanessa Christinet, Eric Comte, et al. · Open Forum Infectious Diseases · 45
PDF
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
2015 · Laura Ciaffi, Sinata Koulla-Shiro, et al. · AIDS · 44
Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon
2008 · Christian Laurent, Anke Bourgeois, et al. · AIDS Research and Human Retroviruses · 41
Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
2010 · Jules B Tchatchueng Mbougua, Christian Laurent, et al. · BMC Public Health · 38
PDF
High rates of active hepatitis B and C co‐infections in HIV‐1 infected Cameroonian adults initiating antiretroviral therapy
2009 · C Laurent, A Bourgeois, et al. · HIV Medicine · 35
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine
2007 · Christian Laurent, Charles Kouanfack, et al. · AIDS · 35
Sexually Transmitted Infections Among Female Sex Workers in Kupang, Indonesia:
2003 · Stephen C. Davies, Brad Otto, et al. · Sexually Transmitted Diseases · 35
Women experience a better long-term immune recovery and a better survival on HAART in Lao People’s Democratic Republic
2013 · Mathieu Bastard, Khamphang Soulinphumy, et al. · BMC Infectious Diseases · 32
PDF
Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa
2016 · Emilande Guichet, Avelin Aghokeng, et al. · AIDS Research and Human Retroviruses · 31
Adherence to Antiretroviral Therapy Assessed by Drug Level Monitoring and Self-Report in Cameroon
2008 · Charles Kouanfack, Christian Laurent, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 31
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship*
2014 · Nilesh B. Bhatt, Elisabeth Baudin, et al. · Journal of Antimicrobial Chemotherapy · 26
PDF
Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
2023 · Abba Aissatou, Joseph Fokam, et al. · Frontiers in Immunology · 12
PDF
APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
2021 · Nongodo Firmin Kabore, Amandine Cournil, et al. · Kidney International Reports · 11
PDF
COVID-19 outbreak investigation and response in a penitentiary setting: the experience of a prison in Italy, February to April 2020
2021 · Ruggero Giuliani, Cristina Cairone, et al. · Eurosurveillance · 9
Switch to etravirine for HIV ‐positive patients receiving statin treatment: a prospective study
2015 · Laura Ciaffi, Matthias Cavassini, et al. · European Journal of Clinical Investigation · 9
PDF
The Follow-Up and Well-Being of Geriatric Outpatients During COVID-19 Pandemic in Cameroon: Insights From the Yaounde Central Hospital
2020 · Marie Josiane Ntsama Essomba, Victorine Nzana, et al. · Gerontology and Geriatric Medicine · 7
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa
2019 · S. Boyer, M. L. Nishimwe, et al. · PharmacoEconomics - Open · 7
Works count: 71
Citation count: 1,267
H-index: 21
I10-index: 23
Year
Topic
Type